Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Point/Counterpoint: Is It Time for Universal Germline Genetic Testing for All GI Cancers?

Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 20 Aug 2022

Hampel Heather, Yurgelun Matthew B

Abstract excerpt

Use of germline genetic testing among patients with cancer is increasing because of (1) the availability of multigene panel tests that include multiple cancer susceptibility genes in a single test, (2) decreased costs of these tests and improvements in insurance coverage, and (3) US Food and Drug Administration-approval of genotype-directed therapies such as poly(ADP-ribose) polymerase inhibitors for individuals...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA gene mutations in cancer
Share to Carcinoma, Ovarian Epithelial

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Genetic Testing

Share to Germ Cells

Share to Germ-Line Mutation

Share to Ovarian Neoplasms

Share to Poly(ADP-ribose) Polymerase Inhibitors

Source

Identifiers

PMID: 35649230
DOI: 10.1200/JCO.21.02764

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Point/Counterpoint: Is It Time for Universal Germline Genetic Testing for All GI Cancers?PMID 35649230Read ↗

Consideration for Multigene Panel Testing Outside of Cancer-Specific Genetic Testing.Semantic proximity Read ↗

Primary Care Implications of the Expanded National Guidelines for Germline Testing of Patients Previously Diagnosed with Colorectal Cancer.Semantic proximity Read ↗

Selection of Germline Genetic Testing Panels in Patients With Cancer: ASCO Guideline.Semantic proximity Read ↗

Germline Cancer Testing in Unselected Patients with Gastric and Esophageal Cancers: A Multi-center Prospective Study.Semantic proximity Read ↗

Upper Gastrointestinal Cancers and the Role of Genetic Testing.Semantic proximity Read ↗

In Our Scope of Practice: Genetic Risk Assessment and Testing for Gastrointestinal Cancers and Polyposis in Gastroenterology.Semantic proximity Read ↗

Screening in GI Cancers: The Role of Genetics.Semantic proximity Read ↗

Personalized Approaches to Gastrointestinal Cancers: Importance of Integrating Genomic Information to Guide Therapy.Semantic proximity Read ↗

The Future of Parallel Tumor and Germline Genetic Testing: Is There a Role for All Patients With Cancer?Semantic proximity Read ↗

Germline Pathogenic Variants Identified in Patients With Genitourinary Malignancies Undergoing Universal Testing: A Multisite Single-Institution Prospective Study.Semantic proximity Read ↗

Multigene Testing for Hereditary Cancer: When, Why, and How.Semantic proximity Read ↗

Universal germline testing among patients with colorectal cancer: clinical actionability and optimised panel.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.